Latest News about ARGX
Recent news which mentions ARGX
Why Is Argenx (ARGX) Stock Up 27% Today?
July 17, 2023
From InvestorPlace
From InvestorPlace
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 17, 2023
From Benzinga
From Motley Fool
After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology
June 28, 2023
From MarketWatch
FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults
June 27, 2023
From Benzinga
From Benzinga
Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis
June 21, 2023
From Benzinga
From Benzinga
From MarketWatch
From Benzinga
From Benzinga
From Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
From Benzinga
From Benzinga
Immunovant Could Potentially Be An M&A Target, Writes Analyst
February 15, 2023
From Benzinga
From Benzinga
Alphabet To $115? Here Are 10 Other Price Target Changes For Thursday
December 22, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.